This article refers to the oral forms of Exelon (capsules and oral solution). The medication also comes in patch form
(see Exelon Patch for more information), which provides the benefits of once-daily dosing and a continuous release of the medication.
Exelon is made by Novartis Pharmaceuticals Corporation.
Exelon is part of a group of medications known as acetylcholinesterase inhibitors.
These medications work by preventing a specific enzyme (known as acetylcholinesterase) from breaking down acetylcholine in the brain. This is a chemical that aids in many brain functions, including memory, attention, reason, and language. It is thought that problems with inadequate acetylcholine in the brain may contribute to some of the
symptoms of dementia due to
Alzheimer's disease or Parkinson's disease.
Exelon is the only acetylcholinesterase inhibitor approved to treat dementia due to Parkinson's disease. The other medications in this class are approved to treat dementia associated with Alzheimer's disease only.